Craft
LeMaitre Vascular

LeMaitre Vascular

Facilities Leased Internationally, square feet

16.47 K

FY, 2020

Revenue

$154.4 M

FY, 2021

Market Capitalization

$1 B

2023-01-30

LeMaitre Vascular Summary

Company summary

Overview
LeMaitre Vascular is a provider of medical devices and human tissue cryopreservation services used in the treatment of peripheral vascular disease, end-stage renal disease, and cardiovascular disease. The company develops, manufactures, and markets vascular devices to address the needs of vascular surgeons, and other specialties such as cardiac surgeons, general surgeons, and neurosurgeons. Its devices are used in arteries and veins outside of the heart.
Type
Public
Status
Active
Founded
1983
HQ
Burlington, MA, US | view all locations
Website
http://www.lemaitre.com
Cybersecurity rating
ESG rating
40-49 out of 100|View all ESG data
Sectors

Key people

  • George W. LeMaitre

    George W. LeMaitre, Chairman and Chief Executive Officer

  • Joseph P. Pellegrino

    Joseph P. Pellegrino, Chief Financial Officer and Board Director

  • David B. Roberts

    David B. Roberts, President, Board Director

  • Laurie A. Churchill

    Laurie A. Churchill, Senior Vice President & General Counsel

Operating MetricsView all

Facilities Leased Internationally, square feet

16.5K
18.1%

FY, 2020

Facilities Owned Internationally, square feet

13K

FY, 2018

Facilities Leased (US), square feet

126.1K
15.3%

FY, 2020

LocationsView all

18 locations detected

  • Burlington, MA HQ

    United States

    63 Second Ave

  • Chandler, AZ

    United States

    2350 E Germann Rd Building 3, Suite 38

  • Fox River Grove, IL

    United States

    912 Northwest Hwy

  • North Brunswick Township, NJ

    United States

    206 N Center Dr

  • Kensington, VIC

    Australia

    49 Stubbs St

  • Vaughan, ON

    Canada

    9135 Keele St, Suite B6

and 12 others

LeMaitre Vascular Financials

Summary financials

Revenue (Q3, 2022)
$39.0M
Gross profit (Q3, 2022)
$25.1M
Net income (Q3, 2022)
$5.5M
Cash (Q3, 2022)
$16.9M
EBIT (Q3, 2022)
$6.2M
Enterprise value
$1.0B

Footer menu